Soleus Capital Management »

Vir Biotechnology shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $18M 2.0M 8.96

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Celcuity (CELC)
Tg Therapeutics (TGTX)
Insulet Corporation (PODD)
Novocure Ord Shs (NVCR)
United Therapeutics Corporation (UTHR)
Praxis Precision Medicines I Com New (PRAX)
Vericel (VCEL)
Alkermes SHS (ALKS)
Biosante Pharmaceuticals (ANIP)
Globus Med Cl A (GMED)
Geron Corporation (GERN)
Twist Bioscience Corp (TWST)
Edgewise Therapeutics (EWTX)
Beta Bionics (BBNX)

View all positions for Soleus Capital Management

Top funds holding Vir Biotechnology

BlackRock
Arch Venture Corp
Vanguard Group
Sb Investment Advisers
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
FMR
Morgan Stanley
ADAR1 Capital Management
Geode Capital Management
Dimensional Fund Advisors
Citadel Advisors
Soleus Capital Management

View all funds holding Vir Biotechnology